Medline ® Abstract for Reference 45
of 'Treatment of menopausal symptoms with hormone therapy'
45
TI
Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement.
AU
Santoro N, Braunstein GD, Butts CL, Martin KA, McDermott M, Pinkerton JV
SO
J Clin Endocrinol Metab. 2016 Apr;101(4):1318-43.
This Scientific Statement finds that there is no rationale for routine prescribing of unregulated, untested, and potentially harmful custom compounded bioidentical hormone therapies.
AD
Departments of Obstetrics and Gynecology (N.S.) and Medicine (M.M.), University of Colorado School of Medicine, Aurora, Colorado 80045; Department of Medicine (G.D.B.), Cedars-Sinai Medical Center, Los Angeles, California 90048; Program Leadership (C.L.B.), Biogen, Cambridge, Massachusetts 02142; Department of Medicine (K.A.M.), Massachusetts General Hospital, Boston, Massachusetts 02114; and Department of Obstetrics and Gynecology (J.V.P.), Midlife Health, University of Virginia, Charlottesville, Virginia 22908.
PMID